Clinical Trial Patients Barely Protected By FDA: Study

Law360, New York (September 28, 2007, 12:00 AM EDT) -- The millions of patients that enroll in clinical trials for experimental drugs and medical devices each year are rarely watched over or protected by the U.S. Food and Drug Administration, a federal investigator has found.

Federal health officials were unaware of how many clinical trials were taking place, audited less than 1% of all testing sites and were usually late to the scene, appearing only when the tests were done, according to a report released Friday by Inspector General Daniel R. Levinson of the Department of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.